| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 2.20e-08 | 175 | 102 | 10 | GO:0005178 | |
| GeneOntologyMolecularFunction | fibronectin binding | 4.14e-05 | 38 | 102 | 4 | GO:0001968 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | VWF TNC OBSCN ITGA8 ITGA3 ITGA5 ITGAV ADAM10 SVEP1 PTPRZ1 LYN | 2.43e-04 | 599 | 102 | 11 | GO:0050839 |
| GeneOntologyBiologicalProcess | dendrite development | TANC2 KLHL1 CRTC1 ADAM10 SHANK3 CHRNB2 CELSR2 FCGR2A PTPRZ1 SLITRK5 | 6.92e-06 | 335 | 103 | 10 | GO:0016358 |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 MYCBP2 TNC PPFIBP2 ITGA3 ITGA5 ITGAV ADAM10 SHANK3 SVEP1 CHRNB2 AMIGO1 GRHL1 FCGR2A SLITRK5 C1QC | 2.55e-05 | 974 | 103 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | memory | 3.73e-05 | 183 | 103 | 7 | GO:0007613 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 4.18e-05 | 77 | 103 | 5 | GO:0060425 | |
| GeneOntologyBiologicalProcess | urogenital system development | 4.73e-05 | 79 | 103 | 5 | GO:0001655 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 6.15e-05 | 198 | 103 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 9.32e-05 | 91 | 103 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.06e-04 | 373 | 103 | 9 | GO:0007611 | |
| GeneOntologyBiologicalProcess | behavior | GPI COL6A1 KLHL1 ITGA8 CRTC1 ITGA3 ITGA5 FIGN ADCY5 SHANK3 CHRNB2 PTPRZ1 SLITRK5 CSMD1 | 1.37e-04 | 891 | 103 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 1.47e-04 | 4 | 103 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | intrahepatic bile duct development | 1.47e-04 | 4 | 103 | 2 | GO:0035622 | |
| GeneOntologyBiologicalProcess | response to bleomycin | 1.47e-04 | 4 | 103 | 2 | GO:1904975 | |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 MYCBP2 TNC PPFIBP2 ITGA3 ADAM10 SHANK3 CHRNB2 AMIGO1 FCGR2A SLITRK5 C1QC | 1.58e-04 | 685 | 103 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.67e-04 | 103 | 103 | 5 | GO:0002437 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.62e-04 | 62 | 103 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | cognition | 2.70e-04 | 423 | 103 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 2.80e-04 | 115 | 103 | 5 | GO:0097061 | |
| GeneOntologyBiologicalProcess | metanephric tubule formation | 3.66e-04 | 6 | 103 | 2 | GO:0072174 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.96e-04 | 124 | 103 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 4.02e-04 | 29 | 103 | 3 | GO:0048745 | |
| GeneOntologyBiologicalProcess | lung development | 4.05e-04 | 269 | 103 | 7 | GO:0030324 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | GPI FOSL2 ADAM10 SVEP1 CHRNB2 DHX9 CACTIN POLR3B FCGR2A BTN1A1 C1QC MAPK3 LYN RBM47 NOTCH2 MASP2 | 4.26e-04 | 1242 | 103 | 16 | GO:0002684 |
| GeneOntologyBiologicalProcess | neuron projection organization | 4.42e-04 | 127 | 103 | 5 | GO:0106027 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 4.43e-04 | 273 | 103 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 4.79e-04 | 198 | 103 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | gland development | 4.80e-04 | 558 | 103 | 10 | GO:0048732 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 4.90e-04 | 73 | 103 | 4 | GO:0060135 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 4.90e-04 | 73 | 103 | 4 | GO:0071300 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 5.01e-04 | 561 | 103 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 5.10e-04 | 7 | 103 | 2 | GO:0072282 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 4.25e-07 | 59 | 102 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | integrin complex | 4.54e-07 | 32 | 102 | 5 | GO:0008305 | |
| GeneOntologyCellularComponent | proteasome core complex | 1.21e-04 | 20 | 102 | 3 | GO:0005839 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.65e-04 | 405 | 102 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | dendritic spine | 1.85e-04 | 242 | 102 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 2.10e-04 | 247 | 102 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.23e-04 | 332 | 102 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | postsynapse | TANC2 ITGA8 CRTC1 ITGA3 ITGA5 ADAM10 SHANK3 CHRNB2 FCGR2A PTPRZ1 STRN4 SLITRK5 C1QC LYN | 4.21e-04 | 1018 | 102 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 ITGA8 MAP1LC3A CRTC1 ITGA3 ITGA5 ADAM10 SHANK3 PTPRZ1 C1QC MAPK3 LYN | 6.29e-04 | 817 | 102 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.96e-04 | 503 | 102 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 9.92e-04 | 519 | 102 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | side of membrane | VWF DTNA ITGA8 ITGA3 ITGA5 ITGAV CHRNB2 MELTF FCGR2A BTN1A1 LYN CTSL | 1.14e-03 | 875 | 102 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.16e-03 | 161 | 102 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.24e-03 | 431 | 102 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.26e-03 | 11 | 102 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | proteasome core complex, beta-subunit complex | 1.26e-03 | 11 | 102 | 2 | GO:0019774 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.78e-03 | 13 | 102 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.94e-03 | 108 | 102 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.20e-03 | 583 | 102 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.59e-03 | 56 | 102 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | cell surface | VWF ITGA8 ITGA3 ITGA5 ITGAV ADAM10 CHRNB2 MELTF FCGR2A BTN1A1 LYN CTSL NOTCH2 | 2.91e-03 | 1111 | 102 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | dendrite | TANC2 KLHL1 ITGA8 CRTC1 ADAM10 SHANK3 AMIGO1 FCGR2A PTPRZ1 STRN4 MAP1LC3B | 3.10e-03 | 858 | 102 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 KLHL1 ITGA8 CRTC1 ADAM10 SHANK3 AMIGO1 FCGR2A PTPRZ1 STRN4 MAP1LC3B | 3.16e-03 | 860 | 102 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | autolysosome | 3.43e-03 | 18 | 102 | 2 | GO:0044754 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.70e-03 | 210 | 102 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | proteasome complex | 4.31e-03 | 67 | 102 | 3 | GO:0000502 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.43e-03 | 530 | 102 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | filopodium membrane | 4.66e-03 | 21 | 102 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | extracellular matrix | 4.79e-03 | 656 | 102 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.89e-03 | 658 | 102 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | nuclear matrix | 4.93e-03 | 140 | 102 | 4 | GO:0016363 | |
| Domain | Integrin_alpha_C_CS | 1.39e-06 | 16 | 101 | 4 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.33e-06 | 18 | 101 | 4 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 2.33e-06 | 18 | 101 | 4 | PS00242 | |
| Domain | Integrin_alpha2 | 2.33e-06 | 18 | 101 | 4 | PF08441 | |
| Domain | Integrin_alpha | 2.33e-06 | 18 | 101 | 4 | IPR000413 | |
| Domain | Int_alpha | 2.93e-06 | 19 | 101 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.93e-06 | 19 | 101 | 4 | IPR013519 | |
| Domain | FG_GAP | 5.47e-06 | 22 | 101 | 4 | PS51470 | |
| Domain | FG-GAP | 7.88e-06 | 24 | 101 | 4 | PF01839 | |
| Domain | FG-GAP | 7.88e-06 | 24 | 101 | 4 | IPR013517 | |
| Domain | Integrin_dom | 9.34e-06 | 25 | 101 | 4 | IPR032695 | |
| Domain | Integrin_alpha | 2.45e-05 | 11 | 101 | 3 | PF00357 | |
| Domain | Kinesin-like_fam | 8.45e-05 | 43 | 101 | 4 | IPR027640 | |
| Domain | - | 9.26e-05 | 44 | 101 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 9.26e-05 | 44 | 101 | 4 | PF00225 | |
| Domain | KISc | 9.26e-05 | 44 | 101 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 9.26e-05 | 44 | 101 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 9.26e-05 | 44 | 101 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 9.26e-05 | 44 | 101 | 4 | PS50067 | |
| Domain | Proteasome | 1.40e-04 | 19 | 101 | 3 | PF00227 | |
| Domain | Proteasome_sua/b | 1.40e-04 | 19 | 101 | 3 | IPR001353 | |
| Domain | VWA | 2.38e-04 | 56 | 101 | 4 | PF00092 | |
| Domain | - | 2.86e-04 | 24 | 101 | 3 | 3.60.20.10 | |
| Domain | EGF | 2.88e-04 | 235 | 101 | 7 | SM00181 | |
| Domain | EGF_3 | 2.88e-04 | 235 | 101 | 7 | PS50026 | |
| Domain | EGF_extracell | 3.11e-04 | 60 | 101 | 4 | IPR013111 | |
| Domain | EGF_2 | 3.11e-04 | 60 | 101 | 4 | PF07974 | |
| Domain | EGF-like_dom | 4.08e-04 | 249 | 101 | 7 | IPR000742 | |
| Domain | Mg_trans_NIPA | 4.28e-04 | 6 | 101 | 2 | IPR008521 | |
| Domain | Mg_trans_NIPA | 4.28e-04 | 6 | 101 | 2 | PF05653 | |
| Domain | hEGF | 4.56e-04 | 28 | 101 | 3 | PF12661 | |
| Domain | EGF_1 | 4.71e-04 | 255 | 101 | 7 | PS00022 | |
| Domain | EGF_CA | 5.26e-04 | 122 | 101 | 5 | SM00179 | |
| Domain | EGF-like_CS | 5.41e-04 | 261 | 101 | 7 | IPR013032 | |
| Domain | EGF_LAM_2 | 5.60e-04 | 30 | 101 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.60e-04 | 30 | 101 | 3 | PS01248 | |
| Domain | EGF-like_Ca-bd_dom | 5.67e-04 | 124 | 101 | 5 | IPR001881 | |
| Domain | EGF_2 | 5.92e-04 | 265 | 101 | 7 | PS01186 | |
| Domain | EGF | 6.09e-04 | 126 | 101 | 5 | PF00008 | |
| Domain | - | 6.93e-04 | 74 | 101 | 4 | 3.40.50.410 | |
| Domain | Ntn_hydrolases_N | 7.44e-04 | 33 | 101 | 3 | IPR029055 | |
| Domain | Atg8 | 7.94e-04 | 8 | 101 | 2 | PF02991 | |
| Domain | Atg8-like | 7.94e-04 | 8 | 101 | 2 | IPR004241 | |
| Domain | EGF_Lam | 8.86e-04 | 35 | 101 | 3 | SM00180 | |
| Domain | VWFA | 1.02e-03 | 82 | 101 | 4 | PS50234 | |
| Domain | VWA | 1.12e-03 | 84 | 101 | 4 | SM00327 | |
| Domain | Laminin_EGF | 1.13e-03 | 38 | 101 | 3 | IPR002049 | |
| Domain | Kinesin_motor_CS | 1.41e-03 | 41 | 101 | 3 | IPR019821 | |
| Domain | GFP-like | 1.54e-03 | 11 | 101 | 2 | IPR023413 | |
| Domain | PROTEASOME_BETA_2 | 1.54e-03 | 11 | 101 | 2 | PS51476 | |
| Domain | Proteasome_suB-type | 1.54e-03 | 11 | 101 | 2 | IPR023333 | |
| Domain | - | 1.54e-03 | 11 | 101 | 2 | 2.40.155.10 | |
| Domain | PROTEASOME_BETA_1 | 1.54e-03 | 11 | 101 | 2 | PS00854 | |
| Domain | Growth_fac_rcpt_ | 1.59e-03 | 156 | 101 | 5 | IPR009030 | |
| Domain | Proteasome_bsu_CS | 1.84e-03 | 12 | 101 | 2 | IPR016050 | |
| Domain | VWF_A | 2.05e-03 | 99 | 101 | 4 | IPR002035 | |
| Domain | ASX_HYDROXYL | 2.12e-03 | 100 | 101 | 4 | PS00010 | |
| Domain | CUB | 2.36e-03 | 49 | 101 | 3 | PF00431 | |
| Domain | CUB | 2.50e-03 | 50 | 101 | 3 | SM00042 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.62e-03 | 106 | 101 | 4 | IPR000152 | |
| Domain | - | 2.80e-03 | 52 | 101 | 3 | 2.60.120.290 | |
| Domain | Sushi | 2.80e-03 | 52 | 101 | 3 | PF00084 | |
| Domain | CUB | 2.96e-03 | 53 | 101 | 3 | PS01180 | |
| Domain | TPR_8 | 2.96e-03 | 53 | 101 | 3 | PF13181 | |
| Domain | CCP | 3.12e-03 | 54 | 101 | 3 | SM00032 | |
| Domain | SUSHI | 3.46e-03 | 56 | 101 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.63e-03 | 57 | 101 | 3 | IPR000436 | |
| Domain | CUB_dom | 3.63e-03 | 57 | 101 | 3 | IPR000859 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.52e-07 | 76 | 81 | 7 | MM14867 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.04e-07 | 84 | 81 | 7 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.47e-07 | 85 | 81 | 7 | M16441 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.06e-06 | 66 | 81 | 6 | M18 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.12e-06 | 258 | 81 | 10 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.11e-06 | 300 | 81 | 10 | M610 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 8.24e-06 | 23 | 81 | 4 | M47720 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 8.24e-06 | 23 | 81 | 4 | M47537 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.37e-05 | 26 | 81 | 4 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.37e-05 | 26 | 81 | 4 | M47719 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.82e-05 | 199 | 81 | 8 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.86e-05 | 28 | 81 | 4 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.47e-05 | 30 | 81 | 4 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.47e-05 | 30 | 81 | 4 | M47718 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.34e-05 | 68 | 81 | 5 | MM14968 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 6.18e-05 | 119 | 81 | 6 | M27785 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.07e-04 | 82 | 81 | 5 | M594 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.24e-04 | 261 | 81 | 8 | MM15676 | |
| Pathway | WP_FOCAL_ADHESION | 1.45e-04 | 199 | 81 | 7 | M39402 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.50e-04 | 47 | 81 | 4 | MM14925 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.66e-04 | 19 | 81 | 3 | MM15113 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.66e-04 | 90 | 81 | 5 | M835 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 1.76e-04 | 49 | 81 | 4 | M67 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | UBA5 TPP2 PSMA3 PSMB4 PSMB8 KIF4A ITGAV KIF15 FCGR2A BTN1A1 KIF4B LYN CTSL | 2.14e-04 | 719 | 81 | 13 | MM14540 |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.26e-04 | 21 | 81 | 3 | M878 | |
| Pathway | PID_CXCR4_PATHWAY | 2.72e-04 | 100 | 81 | 5 | M124 | |
| Pathway | REACTOME_KINESINS | 3.17e-04 | 57 | 81 | 4 | MM15714 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 3.17e-04 | 57 | 81 | 4 | MM14955 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 3.56e-04 | 106 | 81 | 5 | M518 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 3.62e-04 | 59 | 81 | 4 | M747 | |
| Pathway | REACTOME_KINESINS | 4.12e-04 | 61 | 81 | 4 | M977 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL6A1 PSMA3 PSMB4 PSMB8 KIF4A ITGA5 ITGAV ADAM10 KIF4B MAPK3 LYN | 4.29e-04 | 575 | 81 | 11 | M29853 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 4.38e-04 | 62 | 81 | 4 | MM15521 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55 | 4.82e-04 | 6 | 81 | 2 | M47979 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 5.12e-04 | 245 | 81 | 7 | MM15403 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | GPI TCN1 PSMA3 PSMB4 PSMB8 ITGAV ADAM10 DHX9 POLR3B FCGR2A C1QC MAPK3 LYN CTSL SLC27A2 MASP2 | 5.94e-04 | 1128 | 81 | 16 | M1036 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.53e-04 | 121 | 81 | 5 | M872 | |
| Pathway | WP_FOCAL_ADHESION | 7.16e-04 | 187 | 81 | 6 | MM15913 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.20e-04 | 339 | 81 | 8 | M39736 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 7.57e-04 | 125 | 81 | 5 | M45021 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 8.58e-04 | 74 | 81 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 8.58e-04 | 74 | 81 | 4 | M39462 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 8.72e-04 | 129 | 81 | 5 | M39693 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.48e-04 | 76 | 81 | 4 | M27219 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 9.48e-04 | 76 | 81 | 4 | MM14526 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 9.96e-04 | 77 | 81 | 4 | MM15698 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.96e-04 | 77 | 81 | 4 | MM14670 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.32e-03 | 83 | 81 | 4 | M8728 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.33e-03 | 38 | 81 | 3 | MM14874 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION | 1.42e-03 | 10 | 81 | 2 | M47745 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.44e-03 | 39 | 81 | 3 | MM14601 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | GPI PSMA3 PSMB4 PSMB8 ITGAV ADAM10 DHX9 FCGR2A C1QC MAPK3 LYN CTSL SLC27A2 MASP2 | 1.48e-03 | 995 | 81 | 14 | MM14661 |
| Pathway | REACTOME_HEMOSTASIS | 1.55e-03 | 571 | 81 | 10 | MM14472 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.71e-03 | 150 | 81 | 5 | MM14889 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.73e-03 | 302 | 81 | 7 | M39719 | |
| Pathway | REACTOME_RECEPTOR_MEDIATED_MITOPHAGY | 1.73e-03 | 11 | 81 | 2 | M27789 | |
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 1.92e-08 | 28 | 103 | 5 | 21335239 | |
| Pubmed | Mass spectrometric based mapping of the disulfide bonding patterns of integrin alpha chains. | 2.52e-08 | 3 | 103 | 3 | 14596610 | |
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 3.53e-08 | 12 | 103 | 4 | 10090148 | |
| Pubmed | 3.90e-08 | 32 | 103 | 5 | 23154389 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 26524591 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 1.28e-07 | 16 | 103 | 4 | 12904471 | |
| Pubmed | 3.39e-07 | 20 | 103 | 4 | 22687584 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL6A1 MYCBP2 KIF4A ITGA3 ITGA5 ITGAV ADAM10 CDKAL1 USP5 MELTF CELSR2 MANEAL SLITRK5 MYDGF CTSL NOTCH2 | 4.95e-07 | 1201 | 103 | 16 | 35696571 |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 1690718 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 16424009 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 19141530 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 9686317 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 6.15e-07 | 23 | 103 | 4 | 23152823 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.92e-07 | 248 | 103 | 8 | 24006456 | |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 8.75e-07 | 25 | 103 | 4 | 17170699 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10091056 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.21e-06 | 27 | 103 | 4 | 31541017 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 15370361 | ||
| Pubmed | Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. | 1.40e-06 | 8 | 103 | 3 | 7691492 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 9553049 | ||
| Pubmed | 2.00e-06 | 69 | 103 | 5 | 28489004 | ||
| Pubmed | Characterization of integrin engagement during defined human embryonic stem cell culture. | 2.09e-06 | 9 | 103 | 3 | 19933311 | |
| Pubmed | Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. | 2.09e-06 | 9 | 103 | 3 | 23640055 | |
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 1693624 | ||
| Pubmed | 2.78e-06 | 33 | 103 | 4 | 33436499 | ||
| Pubmed | Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. | 2.98e-06 | 10 | 103 | 3 | 17716972 | |
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 10742111 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 20493910 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 26682926 | ||
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 5.44e-06 | 12 | 103 | 3 | 28386022 | |
| Pubmed | Transient and lineage-restricted requirement of Ebf3 for sternum ossification. | 5.44e-06 | 12 | 103 | 3 | 32398354 | |
| Pubmed | SOX9 DMXL2 VWF TTC28 MYCBP2 PSMA3 PSMB4 IFIT5 AKAP8L STAB1 POLR3B ATRNL1 PBX1 MPPED2 CTSL | 5.84e-06 | 1285 | 103 | 15 | 35914814 | |
| Pubmed | 6.61e-06 | 153 | 103 | 6 | 25037231 | ||
| Pubmed | 7.06e-06 | 13 | 103 | 3 | 20563599 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 8.69e-06 | 2 | 103 | 2 | 36482480 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32851057 | ||
| Pubmed | Dystrophic muscle in mice chimeric for expression of alpha5 integrin. | 8.69e-06 | 2 | 103 | 2 | 9813102 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 10082751 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 2450560 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 8.69e-06 | 2 | 103 | 2 | 30081192 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 8.69e-06 | 2 | 103 | 2 | 31067151 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16177087 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 8.69e-06 | 2 | 103 | 2 | 10559369 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27363302 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21565503 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7929562 | ||
| Pubmed | Distribution of alpha3, alpha5 and alpha(v) integrin subunits in mature and immature human oocytes. | 8.69e-06 | 2 | 103 | 2 | 9809676 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 10748171 | ||
| Pubmed | Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues. | 8.69e-06 | 2 | 103 | 2 | 19623642 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11402034 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20926544 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 8.69e-06 | 2 | 103 | 2 | 31486502 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9314546 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 10773663 | ||
| Pubmed | Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. | 8.69e-06 | 2 | 103 | 2 | 12923056 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31616463 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 28350061 | ||
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 8.69e-06 | 2 | 103 | 2 | 24658398 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8034133 | ||
| Pubmed | IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils. | 8.69e-06 | 2 | 103 | 2 | 11131153 | |
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 8.69e-06 | 2 | 103 | 2 | 23500491 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 34169461 | ||
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 8.69e-06 | 2 | 103 | 2 | 9658142 | |
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 9311996 | ||
| Pubmed | 1.37e-05 | 16 | 103 | 3 | 15878328 | ||
| Pubmed | 1.37e-05 | 16 | 103 | 3 | 36165446 | ||
| Pubmed | 1.37e-05 | 16 | 103 | 3 | 36910145 | ||
| Pubmed | Human proteasome subunits from 2-dimensional gels identified by partial sequencing. | 1.37e-05 | 16 | 103 | 3 | 7811265 | |
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 1.37e-05 | 16 | 103 | 3 | 9223324 | |
| Pubmed | 1.37e-05 | 16 | 103 | 3 | 11307167 | ||
| Pubmed | 1.42e-05 | 175 | 103 | 6 | 28071719 | ||
| Pubmed | 1.50e-05 | 50 | 103 | 4 | 23658023 | ||
| Pubmed | 1.66e-05 | 17 | 103 | 3 | 15887188 | ||
| Pubmed | Disrupted tenogenesis in masseter as a potential cause of micrognathia. | 1.66e-05 | 17 | 103 | 3 | 36257937 | |
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 1.90e-05 | 53 | 103 | 4 | 1431091 | |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 2.20e-05 | 55 | 103 | 4 | 38945485 | |
| Pubmed | 2.36e-05 | 19 | 103 | 3 | 16319112 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26733684 | ||
| Pubmed | Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. | 2.60e-05 | 3 | 103 | 2 | 19147558 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24011356 | ||
| Pubmed | The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. | 2.60e-05 | 3 | 103 | 2 | 10454582 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27470585 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 16648484 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26674523 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24690104 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26468287 | ||
| Pubmed | Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin. | 2.60e-05 | 3 | 103 | 2 | 27599164 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 8599839 | ||
| Pubmed | Human Adenovirus Type 37 Uses αVβ1 and α3β1 Integrins for Infection of Human Corneal Cells. | 2.60e-05 | 3 | 103 | 2 | 27974569 | |
| Pubmed | Inflammation-induced interstitial migration of effector CD4⁺ T cells is dependent on integrin αV. | 2.60e-05 | 3 | 103 | 2 | 23933892 | |
| Pubmed | Characterisation and use of a functional Gadd45g bacterial artificial chromosome. | 2.60e-05 | 3 | 103 | 2 | 30470800 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 16890532 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 31114135 | ||
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 2.60e-05 | 3 | 103 | 2 | 19158085 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 31944568 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 2.60e-05 | 3 | 103 | 2 | 10978527 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 33526872 | ||
| Pubmed | Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. | 2.60e-05 | 3 | 103 | 2 | 28473400 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21530503 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 10871287 | ||
| Interaction | ANK2 interactions | 4.99e-07 | 98 | 98 | 7 | int:ANK2 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.41e-07 | 18 | 71 | 4 | 1160 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.15e-05 | 46 | 71 | 4 | 622 | |
| GeneFamily | Proteasome | 6.40e-04 | 43 | 71 | 3 | 690 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.46e-03 | 57 | 71 | 3 | 1179 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | SOX9 PSMB8 HMGCS1 ODC1 ITGA3 ITGAV ADAM10 ADCY5 STAB1 MELTF C1QC MAP1LC3B TMC5 PBX1 LYN RBM47 CTSL NOTCH2 | 1.68e-06 | 1276 | 101 | 18 | M39173 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 4.88e-06 | 326 | 101 | 9 | M39074 | |
| Coexpression | ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN | 1.00e-05 | 74 | 101 | 5 | M11516 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.54e-05 | 137 | 101 | 6 | M39241 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | TPP2 DMXL2 MYCBP2 PSMA3 IFIT5 YTHDC1 ADAM10 DHX9 FCGR2A ATRNL1 NIPA2 MAP1LC3B | 1.75e-05 | 705 | 101 | 12 | M1410 |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_UP | 4.86e-05 | 436 | 101 | 9 | M18855 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | 5.54e-05 | 172 | 101 | 6 | M8932 | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 1.95e-08 | 197 | 103 | 8 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|mLN / Region, Cell class and subclass | 1.95e-08 | 197 | 103 | 8 | 20822fce311326765b71337ce501ba44ea14f58f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-07 | 170 | 103 | 7 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-07 | 170 | 103 | 7 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-07 | 175 | 103 | 7 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-07 | 175 | 103 | 7 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-07 | 175 | 103 | 7 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-07 | 175 | 103 | 7 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.71e-07 | 187 | 103 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-07 | 188 | 103 | 7 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.24e-07 | 192 | 103 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 3.35e-07 | 193 | 103 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 3.35e-07 | 193 | 103 | 7 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.35e-07 | 193 | 103 | 7 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.47e-07 | 194 | 103 | 7 | 3e104e85574894c04791252d466d438fc809dde3 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.72e-07 | 196 | 103 | 7 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 3.72e-07 | 196 | 103 | 7 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-07 | 196 | 103 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-07 | 197 | 103 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-07 | 197 | 103 | 7 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-07 | 197 | 103 | 7 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.85e-07 | 197 | 103 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 3.99e-07 | 198 | 103 | 7 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-07 | 198 | 103 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 3.99e-07 | 198 | 103 | 7 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-07 | 198 | 103 | 7 | 01d563ccdc0da02dac04169e713844fecb4233a1 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 4.12e-07 | 199 | 103 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Pleural_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.26e-07 | 200 | 103 | 7 | 1798eb621dccb4ccae18d9b3df558a6428d30542 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-07 | 200 | 103 | 7 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / Condition, Lineage and Cell class | 4.26e-07 | 200 | 103 | 7 | 4c9e936b5e100c1a3ef10ea262febccf8226df9f | |
| ToppCell | BAL-Severe-Myeloid-MoAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-07 | 200 | 103 | 7 | 43ec6732cc255d533170ebf95d282e503606dcc6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Astrocyte|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-07 | 200 | 103 | 7 | 7205e742ad796d548761839d92a4794ee8f17629 | |
| ToppCell | BAL-Severe-Myeloid-MoAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-07 | 200 | 103 | 7 | 60bf9f9d4899245463707016e51cd7243f6405b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-07 | 200 | 103 | 7 | 25b573f4427ecafe050ca90bea459f1b25b451cf | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-06 | 155 | 103 | 6 | 5fabe24a784f0be46040ffc886eabd8d5ce78121 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-06 | 164 | 103 | 6 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.54e-06 | 167 | 103 | 6 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.01e-06 | 172 | 103 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.01e-06 | 172 | 103 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-06 | 173 | 103 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.44e-06 | 176 | 103 | 6 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 178 | 103 | 6 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-06 | 180 | 103 | 6 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-06 | 180 | 103 | 6 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-06 | 180 | 103 | 6 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.91e-06 | 180 | 103 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 3.91e-06 | 180 | 103 | 6 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-06 | 180 | 103 | 6 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-06 | 180 | 103 | 6 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-06 | 180 | 103 | 6 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 4.58e-06 | 185 | 103 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-06 | 187 | 103 | 6 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 5.02e-06 | 188 | 103 | 6 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 5.02e-06 | 188 | 103 | 6 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.17e-06 | 189 | 103 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 189 | 103 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-06 | 189 | 103 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 5.33e-06 | 190 | 103 | 6 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 5.33e-06 | 190 | 103 | 6 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-06 | 191 | 103 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.50e-06 | 191 | 103 | 6 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.50e-06 | 191 | 103 | 6 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.50e-06 | 191 | 103 | 6 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 5.66e-06 | 192 | 103 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-06 | 192 | 103 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.66e-06 | 192 | 103 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 193 | 103 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 5.83e-06 | 193 | 103 | 6 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.83e-06 | 193 | 103 | 6 | 93ba635ed69fec9286fe7636b9d258f3d93a22c3 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.83e-06 | 193 | 103 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.83e-06 | 193 | 103 | 6 | 6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.01e-06 | 194 | 103 | 6 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.01e-06 | 194 | 103 | 6 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.01e-06 | 194 | 103 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 194 | 103 | 6 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.01e-06 | 194 | 103 | 6 | e455cb469157c044126f9b0b308957d4ee1e608b | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 6.01e-06 | 194 | 103 | 6 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 6.01e-06 | 194 | 103 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.01e-06 | 194 | 103 | 6 | a062100ea6cd512a108f9036c259e0cd0f458563 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.01e-06 | 194 | 103 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.01e-06 | 194 | 103 | 6 | e0cfd18a7ea2251163d61312b9397f8a518c8c51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 194 | 103 | 6 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 194 | 103 | 6 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 6.01e-06 | 194 | 103 | 6 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 194 | 103 | 6 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.19e-06 | 195 | 103 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.19e-06 | 195 | 103 | 6 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 6.19e-06 | 195 | 103 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 6.19e-06 | 195 | 103 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.37e-06 | 196 | 103 | 6 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.37e-06 | 196 | 103 | 6 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM3|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.37e-06 | 196 | 103 | 6 | 9faad17aa0b6af5a8ec2dadf7d70b9209d658072 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | ILEUM-inflamed-(3)_Resident_macrophages|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.37e-06 | 196 | 103 | 6 | 5ac246a823a8e1996325753858615269687b429d | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.37e-06 | 196 | 103 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | (000)_CD14+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 6.56e-06 | 197 | 103 | 6 | cff498bc7b153f28dd013eaeb73ead4fb62fb44c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-06 | 197 | 103 | 6 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.56e-06 | 197 | 103 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| Computational | Genes in the cancer module 412. | 1.06e-06 | 13 | 69 | 4 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 2.67e-06 | 16 | 69 | 4 | MODULE_275 | |
| Computational | Genes in the cancer module 321. | 7.86e-05 | 112 | 69 | 6 | MODULE_321 | |
| Computational | Genes in the cancer module 311. | 1.93e-04 | 18 | 69 | 3 | MODULE_311 | |
| Computational | Adhesion molecules. | 2.78e-04 | 141 | 69 | 6 | MODULE_122 | |
| Drug | AC1NRBJE | 4.23e-07 | 152 | 102 | 8 | CID005288446 | |
| Drug | Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.56e-06 | 193 | 102 | 8 | 7187_UP | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 7448_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 6772_UP | |
| Drug | arginyl-glycyl-aspartic acid | 7.19e-06 | 9 | 102 | 3 | ctd:C047981 | |
| Drug | A NATURAL PROTEOSOME INHIBITOR FROM APIOSPORA MONTAGNEI | 8.27e-06 | 29 | 102 | 4 | CID005287563 | |
| Drug | Grgd Peptide | 1.02e-05 | 10 | 102 | 3 | CID000126679 | |
| Drug | phorbol-13-acetate | 1.61e-05 | 326 | 102 | 9 | CID000499953 | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.94e-05 | 184 | 102 | 7 | 3244_UP | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 7143_DN | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 3.01e-05 | 197 | 102 | 7 | 308_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 5463_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 2251_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7012_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5423_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 3.32e-05 | 200 | 102 | 7 | 5921_DN | |
| Drug | diethyl malate | 4.27e-05 | 86 | 102 | 5 | ctd:C058705 | |
| Drug | 4-hydroxynonenal | 5.08e-05 | 471 | 102 | 10 | CID000001693 | |
| Disease | Manic mood | 6.66e-05 | 4 | 99 | 2 | C0564408 | |
| Disease | diabetes mellitus | 8.23e-05 | 68 | 99 | 4 | EFO_0000400 | |
| Disease | Intellectual Disability | 1.34e-04 | 447 | 99 | 8 | C3714756 | |
| Disease | Streptococcal pneumonia | 1.66e-04 | 6 | 99 | 2 | C0155862 | |
| Disease | osteoarthritis biomarker measurement | 1.66e-04 | 6 | 99 | 2 | EFO_0005890 | |
| Disease | waist-hip ratio | DMXL2 TTC28 MYCBP2 CRTC1 EBF1 FIGN ADCY5 CDKAL1 STAB1 KIF9 PBX1 MPPED2 ACOXL | 2.32e-04 | 1226 | 99 | 13 | EFO_0004343 |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 3.08e-04 | 8 | 99 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | COL6A1 TTC28 FOSL2 EBF1 FIGN ADCY5 SVEP1 CDKAL1 PRKD3 HOXA9 MELTF KIF15 MPPED2 | 7.69e-04 | 1392 | 99 | 13 | EFO_0005763 |
| Disease | cardiovascular disease | 8.93e-04 | 457 | 99 | 7 | EFO_0000319 | |
| Disease | body weights and measures, parental genotype effect measurement | 9.88e-04 | 14 | 99 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | Birth Weight | 9.88e-04 | 14 | 99 | 2 | C0005612 | |
| Disease | response to acetylsalicylate | 1.30e-03 | 16 | 99 | 2 | GO_1903492 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.32e-03 | 64 | 99 | 3 | EFO_0008405 | |
| Disease | PR interval | 1.42e-03 | 495 | 99 | 7 | EFO_0004462 | |
| Disease | Astrocytosis | 1.47e-03 | 17 | 99 | 2 | C3887640 | |
| Disease | phosphatidylcholine 40:6 measurement | 1.47e-03 | 17 | 99 | 2 | EFO_0010389 | |
| Disease | Gliosis | 1.47e-03 | 17 | 99 | 2 | C0017639 | |
| Disease | Drugs used in diabetes use measurement | 1.71e-03 | 255 | 99 | 5 | EFO_0009924 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 1.84e-03 | 19 | 99 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Lung Neoplasms | 2.03e-03 | 265 | 99 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.06e-03 | 266 | 99 | 5 | C0242379 | |
| Disease | behavioural disinhibition measurement | 2.08e-03 | 75 | 99 | 3 | EFO_0006946 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 99 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.10e-03 | 160 | 99 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.25e-03 | 163 | 99 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | cotinine measurement | 2.69e-03 | 23 | 99 | 2 | EFO_0007813 | |
| Disease | tobacco smoke exposure measurement | 2.93e-03 | 24 | 99 | 2 | EFO_0009115 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.12e-03 | 293 | 99 | 5 | C1708349 | |
| Disease | Stomach Neoplasms | 3.31e-03 | 297 | 99 | 5 | C0038356 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEYSQYGLGMGFSQA | 236 | Q6P461 | |
| GGVYTCYAMGETFNE | 336 | Q86WK6 | |
| GYMINSDYSVGQSVS | 2096 | Q96PZ7 | |
| AEFQDYYSGVSASMN | 246 | Q13938 | |
| GSNFSMTAGDFQEIY | 286 | Q8N4J0 | |
| GDISFYNMNDGSDIY | 431 | Q13410 | |
| ENGNYIMYARATSGD | 411 | O14672 | |
| ETNNDYETADGGYMT | 276 | P12318 | |
| SYSQTEGNQFTGMAY | 2276 | Q8TDJ6 | |
| YSIMSGNARGQFYLD | 436 | Q9HCU4 | |
| GSTYMAASGLNDSTY | 1126 | O95622 | |
| IGNAMYGNYAAVFAQ | 131 | Q9NUZ1 | |
| YGQDNTTNYGYGMAT | 51 | Q9ULX6 | |
| NGNMYTSSVYGSLAS | 341 | Q01581 | |
| QKNAAAAAAMYGGYA | 556 | A0AV96 | |
| IAGMVAGSEYSGNAY | 391 | Q06710 | |
| NNSTMLGASGDYADF | 91 | P28070 | |
| NMFSTGSGNTYAYGV | 196 | P28062 | |
| DGFLYMVYASQETFG | 106 | Q9GZQ8 | |
| GYGIMTDGYTTYINA | 256 | Q15777 | |
| VNEGMCVTYHNGTGY | 36 | P0DPK3 | |
| VNEGMCVTYHNGTGY | 36 | Q04721 | |
| TGGYSDGLAASQMYS | 381 | P40424 | |
| FYMAGQGDMDSSYGN | 321 | Q5HY92 | |
| QGDMDSSYGNYSYGQ | 326 | Q5HY92 | |
| SCMSGYNGTIFAYGQ | 96 | Q9NS87 | |
| GYSLSGQMDVDENFY | 431 | P26006 | |
| MATTGALGNYYVDSF | 1 | P31269 | |
| MGAGEVANFAAYAFA | 66 | Q8N8Q9 | |
| ADFNTYVAYMESQGA | 26 | B2RXH2 | |
| DTMVYFVGENNGDSS | 491 | O94806 | |
| AFLVYAAGVYSNMGN | 91 | Q9NY33 | |
| AAGVYSNMGNYKSFG | 96 | Q9NY33 | |
| YFQQGDMESNGKYIT | 351 | P06744 | |
| QYIGEGAYGMVSSAY | 46 | P27361 | |
| ALDGYNGTIMCYGQT | 81 | Q9HAQ2 | |
| SGEGTDYINASYIMG | 2071 | P23471 | |
| GYVNSNMENAVGSLY | 441 | Q495T6 | |
| NFTGEQMASYFGYTV | 311 | P53708 | |
| QSGNFYTDTLGMAEF | 511 | Q8ND30 | |
| EDSGQYAAYISNAMG | 5326 | Q5VST9 | |
| NFSGEQMASYFGYAV | 316 | P08648 | |
| ENYENPSSYDSTMGG | 1561 | Q92794 | |
| VNDYYDMVGIQGSDS | 221 | P02747 | |
| MFLYNYIGQDGIASS | 376 | Q8TED4 | |
| YQVSGILDFGDMSYG | 246 | A2RU49 | |
| YTDLANMYAEGGQYS | 341 | Q13325 | |
| NMYAEGGQYSNAEDI | 346 | Q13325 | |
| GMNSEDYVFDSVSGN | 236 | Q9NZI5 | |
| GYDGQSNLSSVEMYD | 531 | O94889 | |
| DNMQYLGEGTYTATA | 866 | Q2UY09 | |
| GQSYAGVVQYSHSQM | 656 | P12109 | |
| GSVFGDAYYEQQMAA | 481 | Q6UUV9 | |
| RVGDFNESTYYMEGN | 201 | Q9UBR1 | |
| NNSDGEYMAGQLAAY | 76 | Q5VV42 | |
| YDGKNMSSLYNFTGE | 286 | P06756 | |
| MYQDYPGNFDTSSRG | 1 | P15408 | |
| GGYTFNYSSFQMVLN | 321 | Q5VV63 | |
| YNSVTTSMNGYGSAA | 481 | Q9UH73 | |
| AAGFDGMYTYFASNG | 316 | Q5VSG8 | |
| GQFGEVWMGYYNNST | 256 | P07948 | |
| GSMNCGEAGQYGVYT | 656 | O00187 | |
| SDSSGVMVYGRYDQF | 156 | Q9Y4J8 | |
| YSMGGAYTAEQENEP | 96 | O95239 | |
| YSMGGAYTAEQENEP | 96 | Q2VIQ3 | |
| STDNQALYGGQMATY | 871 | A0A0U1RQI7 | |
| YMGYTNTDNPFGDNN | 191 | Q8WUQ7 | |
| MGAYTVAAASTFNGF | 386 | P11926 | |
| CEVQVEGYNYTGMGN | 36 | Q08211 | |
| GRISFYMTNYGEEGT | 126 | P12694 | |
| YMTNYGEEGTHVGSA | 131 | P12694 | |
| IMSLNSYNDGDYEGA | 61 | B4DJY2 | |
| YMGWGYQGFASQENT | 71 | Q9BZE2 | |
| EGSSFQMFSSEAYGQ | 306 | P08582 | |
| HMEFYNQYGEQGMSS | 96 | Q5JUQ0 | |
| ETQMYSQNTGGNYFD | 81 | P48380 | |
| GFLSSYGIGMEYDQA | 186 | Q5TEA6 | |
| FYAATEGNIGFMNYA | 361 | O14975 | |
| GAYGQVAHSMASKYQ | 1631 | Q9HCD6 | |
| MENGDVYTFGYGQHG | 956 | O75592 | |
| AGQGTGLYSTFTYMN | 456 | P48436 | |
| DGFLYMVYASQETFG | 106 | Q9H492 | |
| SIMNGYASGSNYSFG | 2151 | Q4LDE5 | |
| YASMYSGNDSFPQNG | 131 | Q7Z7C7 | |
| NNADGMYEVSFYSNA | 121 | P17787 | |
| GLMDYAFQYVQDNGG | 181 | P07711 | |
| DFVNTFDGSMYSFAG | 41 | P04275 | |
| FYGADMGAQNASGNT | 271 | Q9BYB0 | |
| DVSSFNMQYSVYGGG | 706 | O94991 | |
| SGAVNDMATNPDYYT | 501 | Q0IIM8 | |
| FGTVSFYLGYNAMQD | 276 | Q9GZZ9 | |
| NYYFGSQFSVDTGAM | 176 | P20061 | |
| YSGTAGDSMAYHNGR | 2106 | P24821 | |
| QEYGSFGTAEMLNYS | 231 | P29144 | |
| STFYGMLLGYANATQ | 2336 | Q9NY15 | |
| FMLGSYSVNDGAQLY | 136 | P25788 | |
| GQNATVAVMSYSGYD | 736 | Q9NW08 | |
| NGSYNDYVREFHNMG | 586 | Q96MU7 | |
| TMAAGEVANFGAYAF | 111 | Q0D2K0 | |
| ELSDYAAQGRAYGNM | 506 | Q96AY4 | |
| AVAMGSNSEYCYSGG | 496 | Q9NRL3 | |
| GNSGASYNMQLAYIF | 516 | Q6UXY8 | |
| AVYYTGNSGAEAAMN | 676 | P45974 | |
| ANYLSNGCDSYGMQD | 471 | O95405 | |
| GGYDGQTYLNTMESY | 706 | Q9NR64 | |
| YTCMFTYASQGGTNE | 61 | Q969H8 | |
| EQYGQMYIKASGSYA | 281 | Q96BF6 |